Haleon plc (NYSE:HLN) Shares Purchased by Hantz Financial Services Inc.

Hantz Financial Services Inc. grew its holdings in Haleon plc (NYSE:HLN - Free Report) by 43.0% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 604,946 shares of the company's stock after purchasing an additional 182,015 shares during the quarter. Hantz Financial Services Inc.'s holdings in Haleon were worth $5,771,000 as of its most recent SEC filing.

Other large investors have also made changes to their positions in the company. Fortitude Family Office LLC acquired a new stake in shares of Haleon in the 3rd quarter worth $28,000. Versant Capital Management Inc grew its stake in shares of Haleon by 2,029.1% in the 4th quarter. Versant Capital Management Inc now owns 3,513 shares of the company's stock valued at $34,000 after buying an additional 3,348 shares during the period. Toronto Dominion Bank increased its holdings in shares of Haleon by 3,470.0% during the 3rd quarter. Toronto Dominion Bank now owns 3,570 shares of the company's stock worth $38,000 after buying an additional 3,470 shares during the last quarter. Geneos Wealth Management Inc. purchased a new stake in shares of Haleon during the 4th quarter valued at approximately $35,000. Finally, Prospera Private Wealth LLC purchased a new position in Haleon in the third quarter worth approximately $57,000. 6.67% of the stock is currently owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

A number of analysts have issued reports on the company. Morgan Stanley lowered Haleon from an "overweight" rating to an "equal weight" rating in a research report on Friday, January 10th. Sanford C. Bernstein cut Haleon from an "outperform" rating to a "market perform" rating in a report on Wednesday, January 8th. Three analysts have rated the stock with a hold rating, three have given a buy rating and one has issued a strong buy rating to the company. Based on data from MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and an average price target of $10.95.

Haleon Stock Up 0.2 %

Shares of NYSE:HLN traded up $0.02 during trading on Thursday, hitting $9.55. 9,503,113 shares of the company were exchanged, compared to its average volume of 11,517,728. The company has a debt-to-equity ratio of 0.44, a current ratio of 0.84 and a quick ratio of 0.58. The firm's 50 day moving average price is $9.54 and its 200-day moving average price is $9.75. The stock has a market capitalization of $43.21 billion, a P/E ratio of 28.10, a PEG ratio of 2.60 and a beta of 0.29. Haleon plc has a 12-month low of $7.89 and a 12-month high of $10.80.

Haleon (NYSE:HLN - Get Free Report) last posted its quarterly earnings data on Thursday, October 31st. The company reported $0.14 earnings per share for the quarter, beating the consensus estimate of $0.11 by $0.03. The business had revenue of $3.62 billion during the quarter, compared to the consensus estimate of $3.74 billion. Haleon had a return on equity of 14.76% and a net margin of 10.85%. During the same period in the prior year, the company earned $0.10 earnings per share. On average, research analysts predict that Haleon plc will post 0.44 earnings per share for the current fiscal year.

About Haleon

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands.